Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08610572Aexternal-prioritypatent/GB2189698A/en
Application filed by Ab HasslefiledCriticalAb Hassle
Publication of MY102850ApublicationCriticalpatent/MY102850A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
PHARMACEUTICAL PREPARATION CONTAINING OMEPRAZOLE TOGETHER WITH AN ALKALINE REACTING COMPOUND OR AN ALKALINE SALT OF OMEPRAZOLE OPTIONALLY TOGETHER WITH AN ALALINE COMPOUND AS THE CORE MATERIAL, ONE OR MORE SUBCOATING LAYERS COMPRISING INERT REACTING COMPOUNDS WHICH ARE SOLUBLE OR RAPIDLY DISINTEGRATING IN WATER, OR POLYMERIC, WATER SOLUBLE FILMFORMING COMPOUNDS, OPTIONALLY PH-BUFFERING ALKALINE COMPOUNDS AND AN ENTERIC COATING AS WELL AS A PROCESS FOR THE PREPARATION THEREOF AND THE USE IN THE TREATMENT OF GASTROINTESTINAL DISEASES.
MYPI87000543A1986-04-301987-04-25New pharmaceutical preparation for oral use.
MY102850A
(en)
3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alcanoic acids,process for their preparation,their pharmaceutical preparation as well their therapeutic use
PLATINUM-DIAMIN COMPLEXES, PROCEDURE FOR THEIR PREPARATION, PROCEDURE FOR THE PREPARATION OF A MEDICAL COMPOSITION CONTAINING SUCH PLATINUM-DIAMIN COMPLEXES FOR THE TREATMENT OF CANCER, AS WELL AS THE COMPOSITION SO MADE.
1-carboxyalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
Pharmaceutical compositions for the treatment of tumor cell metastasis and growths containing 3-methyl-1-(2-(2-naphthyloxy)-ethyl)-2-pyrazolin-5-one or a pharmaceutically acceptable salt thereof,and their preparation
1-carboxy-azaalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
Process for the production of controlled release medical preparations for the treatment of dopamine-deficiency, containing a combination of active substances